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Abstract. There is a growing amount of clinical, anatomical and func-
tional evidence for the heterogeneous presentation of neuropsychiatric
and neurodegenerative diseases such as schizophrenia and Alzheimer’s
Disease (AD). Elucidating distinct subtypes of diseases allows a better
understanding of neuropathogenesis and enables the possibility of devel-
oping targeted treatment programs. Recent semi-supervised clustering
techniques have provided a data-driven way to understand disease het-
erogeneity. However, existing methods do not take into account that sub-
types of the disease might present themselves at different spatial scales
across the brain. Here, we introduce a novel method, MAGIC, to un-
cover disease heterogeneity by leveraging multi-scale clustering. We first
extract multi-scale patterns of structural covariance (PSCs) followed by
a semi-supervised clustering with double cyclic block-wise optimization
across different scales of PSCs. We validate MAGIC using simulated het-
erogeneous neuroanatomical data and demonstrate its clinical potential
by exploring the heterogeneity of AD using T1 MRI scans of 228 cogni-
tively normal (CN) and 191 patients. Our results indicate two main sub-
types of AD with distinct atrophy patterns that consist of both fine-scale
atrophy in the hippocampus as well as large-scale atrophy in cortical re-
gions. The evidence for the heterogeneity is further corroborated by the
clinical evaluation of two subtypes, which indicates that there is a sub-
population of AD patients that tend to be younger and decline faster in
cognitive performance relative to the other subpopulation, which tends
to be older and maintains a relatively steady decline in cognitive abilities.
Keywords: semi-supervised · clustering · multi-scale.
1 Introduction
Imaging patterns of various brain diseases, such as schizophrenia (SCZ) [1,2,3]
and Alzheimer’s Disease (AD) [4,5,6] are often investigated via group compar-
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isons involving voxel-based or vertex-based statistical analyses. However, such
approaches typically assume that a unique pathological pattern exists in the
disease group and are agnostic to the potential heterogeneity of neuropatho-
genesis due to unobserved endophenotypes. Ignoring heterogeneity may lead to
underpowered statistical conclusions due to the violation of the unimodality as-
sumption of effect loci in the group comparisons.
Several previous studies have made efforts to reveal the heterogeneous clin-
ical biomarkers by leveraging machine learning (ML) and neuroimaging tech-
niques. These studies can be generally divided into two classes based on whether
the data clustering is unsupervised or semi-supervised. Unsupervised clustering
[7,8,9] aims to directly cluster the patients with regard to their demographic in-
formation, clinical presentation or imaging biomarkers. However, unsupervised
clustering techniques rely on similarity or dissimilarity measures across the pa-
tient group only, which can potentially be confounded by covariate effects such as
age, sex and other sources of variation that are not related to the disease effect.
These confounds may overpower and mask the true heterogeneous pathological
effects caused by the disease. Moreover, the optimal number of clusters (c) is
often set apriori, instead of being determined by cross-validation (CV). Alterna-
tively, several recent techniques have been proposed to utilize semi-supervised
clustering to distinguish heterogeneous disease effects. In [11], the authors pro-
pose a method, termed HYDRA, to discriminate between controls and patients
using a convex-polytope classifier while simultaneously clustering the patient
subgroups. The covariate effects, such as age and sex, are regressed out and the
optimal number of clusters is decided via a CV procedure. Moreover, the au-
thors demonstrate HYDRA’s superiority over other unsupervised methods, such
as K-means. However, HYDRA performs clustering inference using an input set
of features that reflect a single spatial scale of anatomy captured by an apriori
determined set of regions of interest (ROI) and may not be able to capture het-
erogeneous patterns that span a wider spectrum of spatial scales. This may lead
to an inaccurate exposition of the heterogeneous disease patterns presented in
the clinical study.
To address this limitation, we propose a novel method, Multi-scAle hetero-
Geneity analysIs and Clustering (MAGIC)1, for parsing multi-scale disease het-
erogeneity. MAGIC first extracts multi-scale, from macro to micro, patterns of
structural covariance (PSCs), analogously with atlas-based ROIs, via orthogo-
nal projective non-negative matrix factorization (OPNMF) [12]. Then a semi-
supervised clustering procedure through a double cyclic block-wise optimization
[13] is leveraged to yield robust clusters. Furthermore, MAGIC allows to obtain
a data-driven parcellation that can explain the heterogeneity the most, thus can
also be seen as a heterogeneity aware segmentation technique.
To demonstrate our claims, we first validate MAGIC on simulated effect
data with the known number of clusters and multi-scale atrophy patterns. Here
we show that MAGIC recovers both the underlying imaging patterns and the
correct number of clusters. We then apply MAGIC to ADNI data to disentangle
1 https://github.com/anbai106/MAGIC
3Fig. 1. The schematic diagram of MAGIC.
the heterogeneity of AD which reveals two distinct subtypes, where one subtype
presents macro-scale cortical atrophy while the latter subtype exhibits focused
hippocampus atrophy.
2 Method
All T1-weighted (T1w) MR images underwent the following image preprocessing
procedure: Brain tissue segmentation was performed using a multi-atlas segmen-
tation technique[14] and was then transformed to produce tissue density maps.
Gray matter (GM) tissue density maps were smoothed and harmonized by esti-
mating age and gender effects in CN using a voxel-wise linear model.
The schematic diagram of MAGIC is shown in Fig. 1. Let the input data (i.e.,
GM density maps) consist of N subjects, with D features for each subject. All
participants are labeled as 1 for AD and -1 for CN. The input data are denoted
as: X “ pxi, yiqNi“1 pX P RDˆN and y P t´1, 1u).
2.1 Representation Learning for Multi-scale PSCs Extraction
In MAGIC, orthogonal projection NMF [12] is used for multi-scale PSCs extrac-
tion. Low dimensional features can be extracted from coarse to refined scales
with different predefined number of PSCs (K ). The general form of the NMF
can be defined as:
}X ´CL}2F subject to C ě 0, L ě 0, CCT “ I (1)
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where matrix C “ rc1, ..., cKs contains the K estimated PSCs. ci P RD and
is assumed to be a unit vector }ci}2 “ 1. I represents the identity matrix. We
refer C P RDˆK as component matrix and L P RKˆN as loading coefficient
matrix. Both C and L are non-negative and indispensable to approximate the
original dataX. Apart from being non-negative, another constraint we explicitly
impose is that L is estimated as the orthogonal projection of the input X to the
components C pL “ CTX).
The component matrix is a sparse part-based representation and conveys
the information regarding the spatial properties of the variability effect. On the
other hand, the loading coefficient matrix is a low level feature representation
which quantifies the strength of those spatial properties in each data sample. In
the current work, we take K from 2 to 60, resulting in 59 sets of single-scale
PSCs and 1829 PSCs in total.
2.2 Clustering via Max-margin Multiple SVM Classifiers
MAGIC constructs the convex-polytope classifier in the same way as HYDRA
does [11]. For each clustering subproblem, MAGIC takes a specific scale of PSCs
as input features (LT ,L P RKˆN ) and corresponding y P t´1, 1u as labels.
In a nutshell, the polytope in the search space is made up by all support
vector machine (SVM) hyperplanes: each hyperplane contributes to one face of
the polytope. Without loss of generality, let us confine CN to be in the inte-
rior of the polytope. MAGIC aims to correctly classify all CN and at least one
SVM correctly classify each patient. The objective of maximizing the polytope’s
margin can be summarized as:
max
twj ,bjucj“1
1
c
cÿ
j“1
2
}wj}2
subject to wTj L
T
i ` bj ď ´1, if yj “ ´1; wTj LTi ` bj ě 1, if yj “ 1
(2)
where wj and bj are the weight and bias, respectively and are sufficient statistics
to define the faces of the convex polytope. In general, this optimization routine
is non-convex and is solved by iterating on solving for cluster memberships and
solving for polytope faces’ parameters [11].
2.3 Double Cyclic Block-wise Optimization
MAGIC adopts a double cyclic block-wise optimization procedure in order to
combine the knowledge from different scales of PSCs. The block-wise optimiza-
tion solves the clustering problem in the form of
max
pw1,b1q,...,pwa,baq
zppw1, b1q, ..., pwa, baqq (3)
where a P R is the number of iterations/blocks that the optimization takes until
the predefined stopping criterion achieves. pwa, baq is the weight and bias term
derived by the a-th set of PSCs.
5The cyclic block-wise optimization (i.e., blue dotted arrow in Fig. 1) aims
to minimize each specific set of single-scale PSCs (zpwa, baq), while fixing the
remaining blocks. The model is first initialized from a specific set of K PSCs.
Then the model is transferred to the next block for fine-tuning the polytope.
This updating rule was performed in a cyclic order across different K until
consistent clustering results were obtained across scales. This cyclic procedure
can be summarized in the form of
S1 fi zpw1, b1q
...
Sa fi zpzpw1, b1q...zpwa, baqq
(4)
where Sa is the search space for the convex-polytope. The second loop (i.e.,
green dotted arrow in Fig. 1) is to initialize the polytope with different K, in
order to achieve a consensus clustering solution.
3 Experiments
For synthetic data, 364 CN from a healthy control dataset were included and
randomly split into two half-split sets. The first split was defined as CN and
the second as a pseudo patient group. The pseudo patient group was further
divided into two half-split sets for neuroanatomical heterogeneity simulation:
Global cortical and subcortical atrophy were introduced to the first and second
splits, respectively. Atrophy simulation with 10% voxel-wise intensity reduction
was imposed to the predefined regions for each PT splits. For real data, We
applied MAGIC to ADNI 1 data with 228 CN and 191 AD.
The number of clusters c was decided by CV. Stratified repeated holdout
splits [15,16] with 100 repetitions were performed and adjusted rand index
(ARI)[17] was used to quantify the clustering stability. For simulated data, we
compare clustering performance and evaluate classification task performance by
using balanced accuracy (BA). Moreover, each synthetic clustering experiment
was repeated 50 times.
Statistical mapping was performed between the subtypes and CN. A two-
sample t-test was performed for all 1829 PSCs with the significance level as
0.05. Benjamini-Hochberg (BH) adjustment [18] was used for the correction of
multiple comparisons. Furthermore, the effect size (ES) for Cohen’s d [19] was
computed for those PSCs that survived the correction.
4 Results
4.1 Synthetic Experiments
Clustering Stability via Cross-validation Single-scale HYDRA was first
applied to the synthetic data for choosing optimal c. Fig. 2A shows the clustering
stability for different c (c = 2 to 8). In general, unstable phase (K = 2 to 16)
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Fig. 2. Synthetic results. (A): Clustering stability across number of clusters (c = 2 to
8) and number of PSCs (K )= 2 to 60). (B): Clustering performance comparison for
different approaches: Single-scale HYDRA (in red) and MAGIC (in green). The green
star denotes for statistically significant difference. (C): Statistical mapping between
subtypes and CN with MAGIC results.
gives mixed ARIs across different c. In stable plateau phase (K = 25 to 60), c
equals 2 obtains consistent higher ARIs than other c. The stable plateau phase
scales (K = 25 to 60 with step size = 5) were then used for MAGIC.
Clustering Performance Comparison between Approaches The compar-
ison of clustering performance between approaches was shown in Fig. 2B. Over-
all, single-scale HYDRA obtained inferior performance and the highest mean
BA was achieved at K = 38 (0.71 ˘ 0.009). MAGIC used multi-scale PSCs (K
= 25 to 60 with step size = 5) and achieved statistically higher BA compared
to single-scale HYDRA (i.e., mean BA = 0.81˘ 0.014, p-value Î 0.05). Of note,
fitting all 1829 PSCs to HYDRA does not give comparable results.
Neuroanatomical Heterogeneity between Subtypes and CN The neu-
roanatomical spatial patterns based on MAGIC clustering results are displayed
in Fig. 2C. We presented only the PSCs with highest ES, and the corresponding
P-value and ES.
For subtype 1, diffuse cortical atrophy was observable: 1446 out of the 1829
PSCs showed significant difference. Among those 1446 PSCs, the PSC covering
almost the whole cortical regions showed highest ES (1.10). Note that this PSC
was simultaneously extracted from multiple coarser scales (e.g.,K = 6, 7, 8, 4).
7Fig. 3. ADNI data results. (A): Clustering stability across number of clusters (c = 2 to
8) and number of PSCs (K )= 2 to 60). (B): Statistical mapping between subtypes and
CN with MAGIC. (C): 2D multidimensional scaling visualization of the subgroups (in
blue and green) relative to controls (in red) using the top two features that is used in
MAGIC clustering. (D): Classification results for MAGIC polytope and linear SVMs,
respectively.
For subtype 2, focal subcortical atrophy was found. 22 out of the 1829 PSCs were
significantly different. Similarly, the 22 PSCs were the same component from
different K, which encompassed the subcortical structures (i.e., hippocampus,
thalamus, putamen and caudate).
4.2 Alzheimer’s Disease Dataset Experiments
Clustering Stability via Cross-validation Fig. 3A shows the clustering sta-
bility for different c (c = 2 to 8) for single-scale HYDRA. Unstable phase gave
mixed ARIs across different c (K = 2 to 20). In stable plateau phase (K = 25
to 60), c equals 2 obtained consistent higher ARI than other c. Thus we chose
c = 2 to be the optimal number of clusters. The stable plateau phase scales (K
= 25 to 60 with step size = 5) were subsequently used for MAGIC.
Demographic and Clinical Characteristics of clustering subtypes Ta-
ble 1 displayed the demographic and clinical characteristics for ADNI partici-
pants and the corresponding subtypes based on MAGIC. Age and FDG are sig-
nificantly different between two subtypes at baseline. MMSE and ADAS become
significantly different between subtypes changing from baseline to 12 months.
8 J. Wen et al.
Table 1. Demographic and Clinical Characteristics of clustering subtypes. AD patients
(left) and the estimated subtypes of AD (right). APOE4 denotes subjects with at least
one APOE allele present. M12 and bl represent time point at 12 months and baseline,
respectively. * denotes statistical significance.
Characteristics CN(n=228) AD(n=191) Pvalue Sub1(n=134) Sub2(n=57) Pvalue
Age (years) 75.87˘5.03 75.27˘7.46 0.32 73.96˘7.46 78.34˘6.56 6.00e-4*
Sex (female) 110 (48.25) 91 (47.64) 0.98 62 (46.27) 29 (50.88) 0.67
APOE4 61 (26.75) 100 (52.36) 5.13e-17* 90 (67.16) 37 (64.91) 0.15
FDG 6.41˘0.61 5.39˘0.67 1.19e-22* 5.21˘0.63 5.74˘0.62 2.08e-04*
MMSE bl 29.11˘1.00 23.31˘2.04 6.03e-137* 23.31˘2.02 23.29˘2.10 0.96
MMSE M12 29.13˘1.17 22.69˘4.08 3.73e-53* 20.40˘4.44 22.69˘4.08 2.58e-03*
ADAS11 bl 6.21˘2.92 18.67˘6.25 1.07e-92* 18.86˘6.01 18.29˘6.72 0.55
ADAS11 M12 5.52˘2.86 22.66˘9.38 4.92e-81* 24.01˘8.92 19.51˘9.76 5.06e-03*
ADAS13 bl 9.50˘4.19 28.97˘7.57 4.64e-118* 28.23˘8.20 29.34˘7.23 0.35
ADAS13 M12 8.79˘4.58 33.47˘10.89 1.24e-97* 35.11˘10.25 29.78˘11.48 4.44e-03*
Neuroanatomical Heterogeneity between Subtypes and CN Fig. 3B
shows the neuroanatomical spatial patterns for MAGIC results. Two subtypes
showed distinct atrophy patterns. For subtype 1, diffuse atrophy pattern was
established on the whole brain: 1560 out of the 1829 PSCs showed significant
difference. Those PSCs with the highest ES included hippocampus, temporal and
frontal lobe. For subtype 2, focal atrophy pattern was found: 164 out of 1829
PSCs showed a significant difference. Hippocampus regions were highly involved
in this subtype. Further evidence of the anatomical heterogeneity exhibited by
the two subtypes of AD can be seen when the PSCs that MAGIC utilizes in its
classification boundary were projected onto two dimensions using multidimen-
sional scaling. Subtype 1 and 2 in blue and green, respectively exhibit unique
divergences away from CN along with two directions, predominately described
by the presence and absence of cortical atrophy patterns (Fig. 3C).
Individualized Classification via the Two-face Polytope The nature of
MAGIC allows not only for clustering but also for classification via the convex
polytope. For a fair comparison, we randomly split AD patient in the training set
into 2 splits with the same ratio as the two subtypes found in MAGIC (134/57).
Taking the PSCs as features (K = 35) when MAGIC converged, two linear SVMs
were independently run for CN vs first split and CN vs second split of AD to
construct a polytope as in MAGIC. Fig. 3D showed that MAGIC (0.82˘ 0.03)
and the permutation linear SVMs (0.80 ˘ 0.03) obtained comparable results.
Of note, since no advanced procedures, such as nested CV for hyperparameter
searching, was used, the accuracy here is lower compared to state-of-the-art [20].
5 Conclusion
In the current study, we proposed a novel method, MAGIC, for parsing disease
heterogeneity and demonstrated its superiority over HYDRA. The application to
9AD found two robust clinically different subtypes, thus highlighting the potential
of MAGIC in the analysis of the heterogeneity of brain diseases.
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